Dr Katherine Ellen Kowalczyk, DO | |
100 Michigan St Ne # Mc027, Grand Rapids, MI 49503-2560 | |
(616) 391-2160 | |
Not Available |
Full Name | Dr Katherine Ellen Kowalczyk |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 16 Years |
Location | 100 Michigan St Ne # Mc027, Grand Rapids, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295997633 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 5101017587 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Spectrum Health | Grand rapids, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Spectrum Health Hospitals | 8921904764 | 131 |
News Archive
Neisseria meningitidis, the meningococcus, is a bacterium that can cause diseases with high fatality rates, and there has therefore been considerable concern that, like other bacteria, it might become resistant to antibiotics. But now a study from örebro University and örebro University Hospital in Sweden shows that there has not been any increase in resistant meningococci in Sweden over the last 15 years. According to researcher Sara Thulin Hedberg, the reason for this may be that it is not especially advantageous for bacteria to develop resistance.
Identification of a key player in a signaling pathway involved in the development of melanoma - the deadliest form of skin cancer - may offer hope for new targeted melanoma therapies.
A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.
A team of Australian researchers at the Walter and Eliza Hall Institute of Medical Research (WEHI), the Doherty Institute, and the Kirby Institute have identified neutralizing nanobody cocktails that block the SARS-CoV-2 virus from entering cells in pre-clinical models.
› Verified 6 days ago
Entity Name | Spectrum Health Primary Care Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
Neisseria meningitidis, the meningococcus, is a bacterium that can cause diseases with high fatality rates, and there has therefore been considerable concern that, like other bacteria, it might become resistant to antibiotics. But now a study from örebro University and örebro University Hospital in Sweden shows that there has not been any increase in resistant meningococci in Sweden over the last 15 years. According to researcher Sara Thulin Hedberg, the reason for this may be that it is not especially advantageous for bacteria to develop resistance.
Identification of a key player in a signaling pathway involved in the development of melanoma - the deadliest form of skin cancer - may offer hope for new targeted melanoma therapies.
A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.
A team of Australian researchers at the Walter and Eliza Hall Institute of Medical Research (WEHI), the Doherty Institute, and the Kirby Institute have identified neutralizing nanobody cocktails that block the SARS-CoV-2 virus from entering cells in pre-clinical models.
› Verified 6 days ago
Entity Name | Spectrum Health Hospitals |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558407189 PECOS PAC ID: 8921904764 Enrollment ID: O20040120000997 |
News Archive
Neisseria meningitidis, the meningococcus, is a bacterium that can cause diseases with high fatality rates, and there has therefore been considerable concern that, like other bacteria, it might become resistant to antibiotics. But now a study from örebro University and örebro University Hospital in Sweden shows that there has not been any increase in resistant meningococci in Sweden over the last 15 years. According to researcher Sara Thulin Hedberg, the reason for this may be that it is not especially advantageous for bacteria to develop resistance.
Identification of a key player in a signaling pathway involved in the development of melanoma - the deadliest form of skin cancer - may offer hope for new targeted melanoma therapies.
A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.
A team of Australian researchers at the Walter and Eliza Hall Institute of Medical Research (WEHI), the Doherty Institute, and the Kirby Institute have identified neutralizing nanobody cocktails that block the SARS-CoV-2 virus from entering cells in pre-clinical models.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Katherine Ellen Kowalczyk, DO 100 Michigan St Ne, Mc 845, Grand Rapids, MI 49503-2560 Ph: () - | Dr Katherine Ellen Kowalczyk, DO 100 Michigan St Ne # Mc027, Grand Rapids, MI 49503-2560 Ph: (616) 391-2160 |
News Archive
Neisseria meningitidis, the meningococcus, is a bacterium that can cause diseases with high fatality rates, and there has therefore been considerable concern that, like other bacteria, it might become resistant to antibiotics. But now a study from örebro University and örebro University Hospital in Sweden shows that there has not been any increase in resistant meningococci in Sweden over the last 15 years. According to researcher Sara Thulin Hedberg, the reason for this may be that it is not especially advantageous for bacteria to develop resistance.
Identification of a key player in a signaling pathway involved in the development of melanoma - the deadliest form of skin cancer - may offer hope for new targeted melanoma therapies.
A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.
A team of Australian researchers at the Walter and Eliza Hall Institute of Medical Research (WEHI), the Doherty Institute, and the Kirby Institute have identified neutralizing nanobody cocktails that block the SARS-CoV-2 virus from entering cells in pre-clinical models.
› Verified 6 days ago
Dr. Marcos Itamar Cordoba Munoz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 25 Michigan St Ne, Maternal Fetal Medicine Dept, Grand Rapids, MI 49503 Phone: 616-391-3681 | |
Erin Michelle Fricke, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 25 Michigan St Ne Ste 5200, Grand Rapids, MI 49503 Phone: 616-391-3681 | |
Geron D Turke, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1787 Grand Ridge Ct Ne, Suite 201, Grand Rapids, MI 49525 Phone: 616-913-8601 | |
Lisa Anne Andersson-zetye, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2750 E Beltline Ave Ne Fl 1, Grand Rapids, MI 49525 Phone: 616-447-5850 | |
Dr. Andrea C Wolfe, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 329 Saddleback Dr Ne, Grand Rapids, MI 49525 Phone: 616-486-6790 | |
Dr. Mili Thakur, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3230 Eagle Park Dr Ne Ste 100, Grand Rapids, MI 49525 Phone: 616-988-2229 | |
Dr. Gordon Oliver Downey, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 145 Michigan St Ne, Suite 6300, Grand Rapids, MI 49503 Phone: 616-486-6000 Fax: 616-486-2065 |